X0306 4 2021-12-02 false 0001636422 Health Catalyst, Inc. HCAT 0001780980 Burton Daniel D. C/O HEALTH CATALYST, INC. 10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN UT 84095 true true false false Chief Executive Officer Common Stock 2021-12-02 4 F false 4410.00 41.9475 D 241871.00 D Common Stock 2021-12-03 4 M false 21781.00 10.80 A 263652.00 D Common Stock 2021-12-03 4 M false 14431.00 15.84 A 278083.00 D Common Stock 2021-12-03 4 S false 25885.00 40.2787 D 252198.00 D Common Stock 2021-12-03 4 S false 10127.00 41.4684 D 242071.00 D Common Stock 2021-12-03 4 S false 200.00 42.1299 D 241871.00 D Common Stock 2021-12-06 4 M false 11126.00 10.80 A 252997.00 D Common Stock 2021-12-06 4 M false 5881.00 15.84 A 258878.00 D Common Stock 2021-12-06 4 S false 21972.00 40.0617 D 236906.00 D Stock Option (Right to Buy) 15.84 2021-12-03 4 M false 14431.00 0.00 D 2029-02-05 Common Stock 14431.00 94815.00 D Stock Option (Right to Buy) 10.80 2021-12-03 4 M false 21781.00 0.00 D 2028-09-27 Common Stock 21781.00 184399.00 D Stock Option (Right to Buy) 15.84 2021-12-06 4 M false 5881.00 0.00 D 2029-02-05 Common Stock 5881.00 88934.00 D Stock Option (Right to Buy) 10.80 2021-12-06 4 M false 11126.00 0.00 D 2028-09-27 Common Stock 11126.00 173273.00 D Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade. The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1. Represents the weighted average sale price of the shares sold ranging from $40.00 to $40.92 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $41.09 to $41.79 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $42.10 to $42.36 per share, inclusive. Represents the weighted average sale price of the shares sold ranging from $40.00 to $40.35 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) through (7). 25% of the 299,748 shares underlying the option vested in an annual installment on February 5, 2020 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. 25% of the 747,223 shares underlying the option vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. /s/ Daniel Orenstein, as Attorney-in-Fact 2021-12-07